MJ Deals Making Investors profits-THC Therapeutics, Inc. (THCT)

May 22, 2019 -- InvesotrsHub NewsWire -- via microcapspeculators.com -- There have been a ton of deals in the cannabis/CBD space over the past couple months, investors are making a bundle off of these deals; and now are searching for the next opportunities in the space. That’s why we’re highlighting THC Therapeutics, Inc. (USOTC: THCT). THCT also recently differentiated itself when it announced the appointment of Enzo Villani to the company’s Board of Directors. Mr. Villani has raised over $500 million in funding from strategic investors, private equity, venture capital, family offices and the public markets during his over twenty-year career.

THCT’s dHydronator,® can reduce moisture content of Cannabis to 10% in only 10-14 hours. This is the same reason Aurora just signed a deal with EnWave. THCT received patent protection on 20 claims from the US patent office in March ’19 and will be using their patented designs to carve out their piece of the legal cannabis market expected to reach $146.4 billion by 2025.

Today we are highlighting: THC Therapeutics, Inc. (USOTC: THCT), Canopy Growth Corporation (NYSE: CGC), Canopy Rivers (CNPOF), OrganiGram Holdings, Inc. (TSXV: OGI), and Cronos Group, Inc. (NASDAQ: CRON).

THC Therapeutics, Inc. (USOTC: THCT) (Market Cap: $121.185M; Share Price: $8.25) has developed a sanitizing herb dryer, The dHydronator®. Their laboratory-proven product is specifically designed for drying and sanitizing freshly harvested cannabis and herbs. THCT’s product has been tested by two independent laboratories. The testing covered over 6 strains and 9 independent tests to confirm the findings. Over the 9 tests and 6 strains, there was a 4% average increase of THC-A*.

The US patent office has accepted ALL 20 claims for the dHydronator®. The company has received full patent protection for the dHydronator®. This is big. Start your research today.

_________

Canopy Growth Corporation (NYSE: CGC) (Market Cap: $16.174B; Share Price: $46.52) signed an offtake agreement with PharmHouse Inc., a 49 per cent-owned joint venture of Canopy Rivers Inc. (CNPOF) (Market Cap: $454.282M; Share Price: $3.43). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years.

_________

OrganiGram Holdings (TSXV: OGI) (Market Cap: $1.011B; Share Price: $7.86), a leading licensed producer of cannabis, announced that its common shares will commence trading on the Nasdaq Global Select Market under the symbol "OGI" on Tuesday May 21, 2019. Organigram's common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol "OGI".

_________

MediPharm Labs Corp. (MEDIF) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, announced that it has entered into a multi-year supply agreement with Cronos Group, Inc. (NASDAQ: CRON) (Market Cap: $5.5B; Share Price: $16.40). MediPharm Labs will supply Cronos Group with approximately $30 million of high-quality private label cannabis concentrate over 18-months, and, subject to certain renewal and purchase options, potentially up to $60 million over 24-months. In addition, Cronos Group has selected MediPharm Labs’ state of the art extraction facility in Barrie, Ontario, as a preferred partner to fulfill certain of its processing needs, under a separate tolling arrangement.

Legal Disclaimer:

This article was written by Regal Consulting, LLC (“Regal Consulting”). Regal Consulting has agreed to a three-month term consulting agreement with THCT dated 2/14/18. The agreement calls for 50,000 restricted shares of THCT per month. This agreement has been amended to $20,000 per month, and 55,000 shares per month and extended for twelve months ending 3/18/2020. All payments were made directly by THC Therapeutics, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspeculators.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. THCT was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.

http://www.regalconsultingllc.com/full legal disclaimer/

Full Legal Disclaimer Click Here.

Contact Information:

Company Name: ACR Communication LLC.

Contact Person: Media Manager

Email: info@microcapspeculators.com

Phone: 1-702-720-6310

Country: United States

SOURCE: microcapspeculators.com

THC Therapeutics (CE) (USOTC:THCT)
Historical Stock Chart
From Mar 2024 to Apr 2024